PortfoliosLab logo
PortfoliosLab logo
Tools
Portfolios
Screeners
Discussions
ABCL vs. QLD
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between ABCL and QLD is 0.34, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

ABCL vs. QLD

Last updated Jun 1, 2025

Compare and contrast key facts about AbCellera Biologics Inc. (ABCL) and ProShares Ultra QQQ (QLD).

QLD is a passively managed fund by ProShares that tracks the performance of the NASDAQ-100 Index (200%). It was launched on Jun 21, 2006.

Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABCL or QLD.

Performance

ABCL vs. QLD - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in AbCellera Biologics Inc. (ABCL) and ProShares Ultra QQQ (QLD). The values are adjusted to include any dividend payments, if applicable.

Loading data...

Key characteristics

Sharpe Ratio

ABCL:

-0.77

QLD:

0.35

Sortino Ratio

ABCL:

-1.12

QLD:

0.73

Omega Ratio

ABCL:

0.88

QLD:

1.10

Calmar Ratio

ABCL:

-0.52

QLD:

0.32

Martin Ratio

ABCL:

-1.48

QLD:

0.92

Ulcer Index

ABCL:

34.02%

QLD:

14.82%

Daily Std Dev

ABCL:

65.19%

QLD:

50.74%

Max Drawdown

ABCL:

-96.72%

QLD:

-83.13%

Current Drawdown

ABCL:

-96.57%

QLD:

-12.84%

Returns By Period

In the year-to-date period, ABCL achieves a -31.06% return, which is significantly lower than QLD's -3.22% return.

ABCL

YTD

-31.06%

1M

-18.88%

6M

-32.89%

1Y

-48.47%

3Y*

-35.76%

5Y*

N/A

10Y*

N/A

QLD

YTD

-3.22%

1M

15.40%

6M

-3.14%

1Y

17.80%

3Y*

27.80%

5Y*

26.33%

10Y*

27.25%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

AbCellera Biologics Inc.

ProShares Ultra QQQ

Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

ABCL vs. QLD — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
ABCL
The Risk-Adjusted Performance Rank of ABCL is 1111
Overall Rank
The Sharpe Ratio Rank of ABCL is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of ABCL is 1010
Sortino Ratio Rank
The Omega Ratio Rank of ABCL is 1414
Omega Ratio Rank
The Calmar Ratio Rank of ABCL is 1717
Calmar Ratio Rank
The Martin Ratio Rank of ABCL is 66
Martin Ratio Rank
QLD
The Risk-Adjusted Performance Rank of QLD is 3636
Overall Rank
The Sharpe Ratio Rank of QLD is 3333
Sharpe Ratio Rank
The Sortino Ratio Rank of QLD is 3939
Sortino Ratio Rank
The Omega Ratio Rank of QLD is 4040
Omega Ratio Rank
The Calmar Ratio Rank of QLD is 3636
Calmar Ratio Rank
The Martin Ratio Rank of QLD is 3131
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

ABCL vs. QLD - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AbCellera Biologics Inc. (ABCL) and ProShares Ultra QQQ (QLD). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current ABCL Sharpe Ratio is -0.77, which is lower than the QLD Sharpe Ratio of 0.35. The chart below compares the historical Sharpe Ratios of ABCL and QLD, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

ABCL vs. QLD - Dividend Comparison

ABCL has not paid dividends to shareholders, while QLD's dividend yield for the trailing twelve months is around 0.23%.

TTM20242023202220212020201920182017201620152014
ABCL
AbCellera Biologics Inc.		0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
QLD
ProShares Ultra QQQ		0.23%0.25%0.33%0.31%0.00%0.00%0.13%0.06%0.02%0.90%0.11%0.19%

Drawdowns

ABCL vs. QLD - Drawdown Comparison

The maximum ABCL drawdown since its inception was -96.72%, which is greater than QLD's maximum drawdown of -83.13%. Use the drawdown chart below to compare losses from any high point for ABCL and QLD.

Loading data...

Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

ABCL vs. QLD - Volatility Comparison

AbCellera Biologics Inc. (ABCL) has a higher volatility of 15.04% compared to ProShares Ultra QQQ (QLD) at 11.09%. This indicates that ABCL's price experiences larger fluctuations and is considered to be riskier than QLD based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading data...